Why David Einhorn’s Greenlight prefers this tiny biotech over AI ‘excitement’
Greenlight Capital’s third-quarter investor letter had almost nothing good to say about the hot AI trend, but it does have faith in a tiny biotech.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
